Product Description
Erlocip 150 Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal. You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include nausea, vomiting, fatigue, rash, and weight loss. It may cause severe diarrhea, drink plenty of fluids or consult with your doctor if it bothers you. It makes you sensitive towards sunlight, hence wear protective clothing or use sunscreen while going out. In case you develop ulceration in mouth, changes in your vision, or breathing difficulties than it is better to inform the doctor. Your doctor may advise for regular monitoring of liver function while you are taking this medicine.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. It is advised to quit smoking while taking this medicine as it can affect the working of the medicine. If you have to take an antacid or any other medicine, take it at a gap of at least 2 hours after taking the cancer medicine.
How Erlocip Erlotinib WorksErlocip Erlotinib 150mg Tablet employs targeted therapy to block signals that promote the growth of cancer cells. By interfering with specific proteins involved in the development of non-small cell lung cancer and pancreatic cancer, this medicine aims to slow or stop tumor progression, enhancing the effectiveness of treatment protocols for eligible adult patients.
Usage and Administration GuidelinesThis oral tablet is to be used strictly as prescribed by your oncologist or medical practitioner. Swallow the whole tablet with water, and avoid taking it with food unless otherwise instructed, as certain foods may alter drug absorption. Never adjust the dose or discontinue use without consulting your healthcare provider to ensure safety and efficacy.
Benefit and Storage RecommendationsErlocip Erlotinib helps improve treatment outcomes in adults with NSCLC and pancreatic cancer. Proper storage is necessary for maintaining its potency-keep tablets below 30C, protected from sunlight and moisture, and do not use after the 24-month shelf life has expired. Follow these guidelines to safeguard the medication's effectiveness.
FAQ's of Erlocip Erlotinib 150mg Tablet:
Q: What is Erlocip Erlotinib 150mg Tablet used for?
A: Erlocip Erlotinib 150mg Tablet is primarily indicated for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer in adults. It acts by inhibiting specific proteins essential for cancer cell growth.
Q: How should I take Erlocip Erlotinib 150mg Tablet for best results?
A: Take this medicine exactly as prescribed by your oncologist, usually once daily at least one hour before or two hours after eating. Swallow the tablet whole with water, and do not crush or chew it.
Q: When should Erlocip Erlotinib not be used?
A: Do not use Erlocip if you have a known hypersensitivity to Erlotinib or any component of the formulation. Always consult your healthcare provider for eligibility before starting this medication.
Q: Where should I store Erlocip Erlotinib tablets?
A: Store the tablets in a cool, dry place below 30C, protected from moisture and sunlight, and keep the box tightly closed until use.
Q: What are common side effects associated with Erlocip Erlotinib?
A: Some commonly reported side effects include rash, diarrhea, fatigue, and loss of appetite. Inform your doctor if you experience any persistent or severe symptoms while taking this medication.
Q: What benefits does Erlocip offer for cancer patients?
A: Erlocip Erlotinib provides a targeted approach to slow cancer progression and can improve survival outcomes in eligible adults diagnosed with NSCLC or pancreatic cancer when used under medical supervision.
Q: Is Erlocip Erlotinib suitable for all adults and how is dosage determined?
A: This medication is suitable for adults diagnosed with NSCLC or pancreatic cancer as determined by their healthcare provider. The exact dosage and duration are personalized and should be strictly followed as directed by an oncologist.